» Articles » PMID: 3865219

Evolution of Apolipoprotein E: Mouse Sequence and Evidence for an 11-nucleotide Ancestral Unit

Overview
Specialty Science
Date 1985 Dec 1
PMID 3865219
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Apolipoprotein E (apo E) is responsible for the binding of very low density lipoprotein and chylomicron remnants to cellular receptors thereby removing them from circulation. We have isolated and determined the sequence of a cDNA encoding 285 amino acids and the entire 3' untranslated region of 112 nucleotides of mouse apo E. The remaining coding sequence was determined by sequencing mouse liver mRNA. Comparisons with rat and human apo E sequences showed a high degree of conservation although there were regions in each species that were characterized by unique insertions and deletions. Analysis of the sequence homologies within apo E revealed that the entire sequence is made up of repetitive units. The most primitive unit appeared to be an 11-nucleotide repeat within higher order repeats of 22 or 33 nucleotides. The 11-nucleotide unit -TCGGACGAGGC- is read in all three reading frames, and when tandemly repeated, it encodes the highly conserved amino acid sequence Xaa-(Glu/Asp)-(Glu/Asp)-Xaa-Arg-Xaa-Arg-Leu-Gly-Xaa-Xaa. We postulate that apo E and those other apolipoproteins related to it have arisen by duplications and subsequent modifications of this or a closely related 11-nucleotide ancestral sequence.

Citing Articles

Insights into the roles of Apolipoprotein E in adipocyte biology and obesity.

Jiang C, Lin F Int J Obes (Lond). 2024; 48(9):1205-1215.

PMID: 38839985 DOI: 10.1038/s41366-024-01549-9.


Modeling sporadic Alzheimer's disease in mice by combining Apolipoprotein E4 risk gene with environmental risk factors.

Ganesan K, Rentsch P, Langdon A, Milham L, Vissel B Front Aging Neurosci. 2024; 16:1357405.

PMID: 38476659 PMC: 10927790. DOI: 10.3389/fnagi.2024.1357405.


Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation.

Valencia-Olvera A, Balu D, Faulk N, Amiridis A, Wang Y, Pham C Neurotherapeutics. 2023; 20(4):1120-1137.

PMID: 37157042 PMC: 10457278. DOI: 10.1007/s13311-023-01375-3.


Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease.

Cummings J, Ortiz A, Castellino J, Kinney J Eur J Neurosci. 2022; 56(9):5727-5757.

PMID: 35128745 PMC: 9393901. DOI: 10.1111/ejn.15619.


Rodent Models of Amyloid-Beta Feature of Alzheimer's Disease: Development and Potential Treatment Implications.

Poon C, Wang Y, Fung M, Zhang C, Lim L Aging Dis. 2020; 11(5):1235-1259.

PMID: 33014535 PMC: 7505263. DOI: 10.14336/AD.2019.1026.


References
1.
SHORE V, Shore B . Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry. 1973; 12(3):502-7. DOI: 10.1021/bi00727a022. View

2.
Barker W, Dayhoff M . Evolution of lipoproteins deduced from protein sequence data. Comp Biochem Physiol B. 1977; 57(4):309-15. DOI: 10.1016/0305-0491(77)90060-8. View

3.
Proudfoot N, Brownlee G . 3' non-coding region sequences in eukaryotic messenger RNA. Nature. 1976; 263(5574):211-4. DOI: 10.1038/263211a0. View

4.
Maxam A, Gilbert W . A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977; 74(2):560-4. PMC: 392330. DOI: 10.1073/pnas.74.2.560. View

5.
McLachlan A . Repeated helical pattern in apolipoprotein-A-I. Nature. 1977; 267(5610):465-6. DOI: 10.1038/267465a0. View